Abstract:A simple, sensitive and accurate method was developed for the quantification of levodopa and methyldopa (IS) in beagle dog plasma by LC–ESI/MS, chromatographic separation was carried out by a Diamonsil C18 column (150 mm × 4.6 mm i.d., 5 mm) with an ODS guard column maintained at 30 °C. The mobile phase was methanol (A) and 0.5% formic acid aqueous solution (B) system in the gradient elution profile, the retention time of levodopa and IS were 4.8 and 6.1 min, respectively, linear range for levodopa concentration was 0.08-20.0 μg/mL in plasma samples with a correlation coefficient(r) of 0.9978, the limit of detection was 32 ng/mL. CV of intra-day and inter-day assays were all less than 15%, mean recoveries of levodopa were all more than 90% in 0.32, 1.6 and 16.0 μg/mL concentrations of levodopa (n = 3). The validated method was successfully applied to the determination of levodopa in plasma samples, pharmacokinetic of levodopa following a single oral dose of compound levodopa tablets and antiemetic drug – domperidone administrated to beagle dogs has been carried out, the main pharmacokinetic parameters of levodopa with domperidone were as follows: Tmax (0.50 ± 0.18) h, Cmax (39.72 ± 7.91) μg/mL, tl/2 (0.65 ± 0.07) h, AUCo-t (49.01 ± 12.13) μg·h/mL , AUCo-∞ (49.10 ± 12.16) μg·h/mL, we also evaluated the effect of domperidone on pharmacokinetics of levodopa in beagle dog. We thought non-oral sustained-release formulations should be a very good choice instead of this common oral dosage forms on the market, the test results can provide a reference for clinical trials on drug therapy of Parkinson‘s disease.

Bioequivalence of Levodopa and Benserazide Hydrochloride Capsules in Beagle Dogs

Study on Preparation of Levetiracetam Sodium Extended-release Tablet and It's Pharmacokinetics in Beagle Dogs

Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs

Bioavailability of Bicalutamide Tablets in Beagle Dogs

Plasma concentration of sibutramine hydrochloride in beagle dog assayed by LC-MS and study on its pharmacokinetics

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Bioequivalence of Levodopa Tablets in Healthy Volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Study on Pharmacokinetics of Melatonin Orally Disintegrating Tablets and Common Tablets in Beagle Dogs

Pharmacokinetics and bioequivalence of deferiprone extended-release tablets in Beagle dogs

LC–ESI/MS Analysis of Levodopa and Methyldopa (IS) in Beagle Dog Pharmacokinetic Study after Oral Administration and Domperidone Given in Advance

Bioequivalence evaluation of menthol after oral administration of peppermint oil soft capsules in dogs

Pharmacokinetics of piroxicam-β-cyclodextrin inclusion complexes in Beagle dogs

Study on Bioequivalence of Ambroxol Hydrochloride Tablets from Domestic and Import

A single-dose, randomized, crossover bioequivalence study of levamlodipine besilate tablets in healthy subjects

Preliminary Bioequivalence of an Oral Pimobendan Solution Formulation with Reference Solution Formulation in Beagle Dogs

Comparison of the Pharmacokinetics Between the Two Injections of Nimodipine in Beagle

Pharmacokinetic And Bioequivalence Study Of Three Oral Formulations Of Ambroxol 30 Mg: A Randomized, Three-Period Crossover Comparison In Healthy Volunteers

Bioequivalence Test of Domestic Levetiracetam Tablets in Healthy Volunteers

The investigation of the pharmacokinetics of pulsatile-release salbutamol sulfate with pH-sensitive ion exchange resin as the carriers in beagle dogs.